SRM-MS | GenomeWeb

SRM-MS

The study, funded last month by the NIH, will use SRM-MS to identify proteins from a subset of promising pathways that are associated with DKD patients' progression to end-stage disease.

You might say 2012 was the year that proteomics shed its Rodney Dangerfield routine and began to get some respect.

Researchers at Pacific Northwest National Laboratory and the National Cancer Institute have developed a new selected-reaction monitoring mass spectrometry-based technique capable of quantifying proteins at low picogram-per-mL levels without the use of immunoenrichment.

New research by University of Wisconsin-Madison researchers suggests that high-resolution mass spectrometry now offers equivalent or better performance for protein quantitation as triple quadrupole-based selected-reaction monitoring methods.

A team led by researchers at the Swiss Federal Institute of Technology Zurich and the Institute for Systems Biology has developed selected-reaction monitoring mass spec assays for more than 1,000 cancer related proteins in plasma and urine.

In an effort led by Thermo Fisher Scientific's Biomarkers Research Initiatives in Mass Spectrometry Center, several leading proteomics teams have completed a study examining the inter-lab reproducibility of selected-reaction monitoring assays applied to clinical samples treated w

Clinical proteomics firm Expression Pathology has changed its name to OncoPlex Diagnostics and opened a CLIA laboratory in Rockville, Md.

By Adam Bonislawski
Researchers at the Institute for Systems Biology and the Swiss Federal Institute of Technology have developed a new repository for collecting experimental selected-reaction monitoring mass spec data.

By Adam Bonislawski
Scientists at the University of California, San Francisco, have devised a selected-reaction monitoring mass spec workflow to measure the kinetics of caspase-driven proteolysis.

By Adam Bonislawski
Pursuing lower costs and higher throughput, several proteomics researchers are investigating the use of MALDI mass spectrometry for SISCAPA assays.

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.